J. Barcarolo

Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations initiating therapy : modelling study and economic analysis

D. Pillay, A. Phillips, J. Lundgren, 2018 .

Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis.

D. Pillay, A. Phillips, J. Lundgren, 2014, The lancet. HIV.

The role of mathematical modelling in the development of recommendations in the 2013 WHO consolidated antiretroviral therapy guidelines

P. Easterbrook, M. Doherty, G. Hirnschall, 2014, AIDS.

Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

T. F. Rinke de Wit, N. Ford, T. R. D. Wit, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antiretroviral treatment in resource-poor settings: the Brazilian experience

M. Vitoria, P. Teixeira, J. Barcarolo, 2004, AIDS.

The Brazilian experience in providing universal access to antiretroviral therapy.

J. Barcarolo, Teixeira Pr, Vitória Ma, 2003 .

Sustainable financing for Immunization Agenda 2030

U. Griffiths, M. Ranson, H. Saxenian, 2022, Vaccine.

Background paper of the Task Force on Major Diseases and Access to Medicine Subgroup on HIV / AIDS.

P. Wilson, J. Barcarolo, P. Teixeira, 2003 .